Total Revenue | |
---|---|
Cost of Revenue | |
Gross Profit | |
Gross Profit Margin (%) | |
R&D Expense | |
SG&A Expense | |
Total Operating Expenses | |
Operating Income or Loss | |
Operating Margin (%) | |
Interest Expense | |
Total Other Income/Expenses | |
Income Before Tax | |
Income Tax Expense | |
Income from Continuing Ops. | |
Net Income | |
Net Profit Margin (%) | |
Net Income Available to Common Shareholders | |
Basic EPS | |
Diluted EPS | |
Basic Average Shares | |
Diluted Average Shares |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | ||||||||||||
Cost of Revenue | ||||||||||||
Gross Profit | ||||||||||||
Gross Profit Margin (%) | ||||||||||||
R&D Expense | ||||||||||||
SG&A Expense | ||||||||||||
Total Operating Expenses | ||||||||||||
Operating Income or Loss | ||||||||||||
Operating Margin (%) | ||||||||||||
Interest Expense | ||||||||||||
Total Other Income/Expenses | ||||||||||||
Income Before Tax | ||||||||||||
Income Tax Expense | ||||||||||||
Income from Continuing Ops. | ||||||||||||
Net Income | ||||||||||||
Net Profit Margin (%) | ||||||||||||
Net Income Available to Common Shareholders | ||||||||||||
Basic EPS | ||||||||||||
Diluted EPS | ||||||||||||
Basic Average Shares | ||||||||||||
Diluted Average Shares |
Current Assets | |
---|---|
Cash & Cash Equivalents | |
Marketable Securities | |
Receivables | |
Inventories | |
Other Current Assets | |
Total Current Assets | |
Non-Current Assets | |
Marketable Securities | |
PPE Net | |
Intangibles inc. Goodwill | |
Other Non-Current Assets | |
Total Non-Current Assets | |
Total Assets | |
Current Liabilities | |
Accounts Payable | |
Deferred Revenues | |
Debt, Current | |
Accrued Liabilities | |
Other Current Liabilities | |
Total Current Liabilities | |
Non-Current Liabilities | |
Deferred Revenues | |
Debt, Non-Current | |
Other Non-Current Liabilities | |
Total Non-Current Liabilities | |
Total Liabilities | |
Shareholders' Equity | |
Common Stock | |
Additional Paid-In Capital | |
Retained Earnings | |
Other Shareholders' Equity | |
Total Shareholders' Equity | |
Total Liabilities & Shareholders' Equity |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | ||||||||||||
Cash & Cash Equivalents | ||||||||||||
Marketable Securities | ||||||||||||
Receivables | ||||||||||||
Inventories | ||||||||||||
Other Current Assets | ||||||||||||
Total Current Assets | ||||||||||||
Non-Current Assets | ||||||||||||
Marketable Securities | ||||||||||||
PPE Net | ||||||||||||
Intangibles inc. Goodwill | ||||||||||||
Other Non-Current Assets | ||||||||||||
Total Non-Current Assets | ||||||||||||
Total Assets | ||||||||||||
Current Liabilities | ||||||||||||
Accounts Payable | ||||||||||||
Deferred Revenues | ||||||||||||
Debt, Current | ||||||||||||
Accrued Liabilities | ||||||||||||
Other Current Liabilities | ||||||||||||
Total Current Liabilities | ||||||||||||
Non-Current Liabilities | ||||||||||||
Deferred Revenues | ||||||||||||
Debt, Non-Current | ||||||||||||
Other Non-Current Liabilities | ||||||||||||
Total Non-Current Liabilities | ||||||||||||
Total Liabilities | ||||||||||||
Shareholders' Equity | ||||||||||||
Common Stock | ||||||||||||
Additional Paid-In Capital | ||||||||||||
Retained Earnings | ||||||||||||
Other Shareholders' Equity | ||||||||||||
Total Shareholders' Equity | ||||||||||||
Total Liabilities & Shareholders' Equity |
Cash Flows from Operating Activities | |
---|---|
Net Income | |
Depreciation & Amortization | |
Deferred Income Taxes | |
Stock Based Compensation | |
Accounts Receivable | |
Inventory | |
Accounts Payable | |
Deferred Revenue | |
Other Non-Cash | |
Operating Cash Flow | |
Cash Flows from Investing Activities | |
PPE Investments | |
Net Acquisitions | |
Purchase of Investments | |
Sale of Investments | |
Other Investing Activity | |
Investing Cash Flow | |
Cash Flows from Financing Activities | |
Debt Issued | |
Proceeds from Debt Repayment | |
Debt Repayment | |
Proceeds from Sale of Equity | |
Equity Repurchased | |
Dividend Paid | |
Other Financing Activity | |
Financing Cash Flow | |
Cash Position | |
Beginning Cash Position | |
End Cash Position | |
Change in Cash | |
Free Cash Flow | |
Operating Cash Flow | |
Capital Expenditure | |
Free Cash Flow |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||||||||
Net Income | ||||||||||||
Depreciation & Amortization | ||||||||||||
Deferred Income Taxes | ||||||||||||
Stock Based Compensation | ||||||||||||
Accounts Receivable | ||||||||||||
Inventory | ||||||||||||
Accounts Payable | ||||||||||||
Deferred Revenue | ||||||||||||
Other Non-Cash | ||||||||||||
Operating Cash Flow | ||||||||||||
Cash Flows from Investing Activities | ||||||||||||
PPE Investments | ||||||||||||
Net Acquisitions | ||||||||||||
Purchase of Investments | ||||||||||||
Sale of Investments | ||||||||||||
Other Investing Activity | ||||||||||||
Investing Cash Flow | ||||||||||||
Cash Flows from Financing Activities | ||||||||||||
Debt Issued | ||||||||||||
Proceeds from Debt Repayment | ||||||||||||
Debt Repayment | ||||||||||||
Proceeds from Sale of Equity | ||||||||||||
Equity Repurchased | ||||||||||||
Dividend Paid | ||||||||||||
Other Financing Activity | ||||||||||||
Financing Cash Flow | ||||||||||||
Cash Position | ||||||||||||
Beginning Cash Position | ||||||||||||
End Cash Position | ||||||||||||
Change in Cash | ||||||||||||
Free Cash Flow | ||||||||||||
Operating Cash Flow | ||||||||||||
Capital Expenditure | ||||||||||||
Free Cash Flow |